Hepatitis C and human immunodeficiency virus infection
- 1 November 2002
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Hepatology
- Vol. 36 (5B), s201-s209
- https://doi.org/10.1053/jhep.2002.36380
Abstract
In the United States, an estimated 200,000 persons are infected with both hepatitis C virus (HCV) and human immunodeficiency virus (HIV). As the lives of HIV-infected persons have been prolonged by use of highly active antiretroviral therapy, liver disease has emerged as an important, and in some settings, the leading cause of morbidity and mortality. Human immunodeficiency virus infection appears to adversely affect all stages of hepatitis C infec- tion, leading to increased viral persistence and accelerated progression of HCV-related liver disease. In turn, hepatitis C may affect the management of HIV infection, increasing the incidence of liver toxicity caused by antiretroviral medications. The medical management of hepatitis C in HIV-infected persons remains controversial, in part because of the complexity of both infections and potential drug interactions, but chiefly because there is so little published information. Nonetheless, the burden of liver disease is too high to delay man- agement of HIV/HCV-coinfected persons while awaiting better data. Instead, the manage- ment of hepatitis C today must be based on data generated on persons without HIV and an understanding of both infections. Properly designed studies of therapy in HIV/HCV-coin- fected persons are needed to help guide management of these patients in the future. (HEPATOLOGY 2002;36:S201-S209.)Keywords
This publication has 78 references indexed in Scilit:
- Hepatitis C Virus Prevalence among Patients Infected with Human Immunodeficiency Virus: A Cross-Sectional Analysis of the US Adult AIDS Clinical Trials GroupClinical Infectious Diseases, 2002
- Hepatitis C Virus Infection–Related Morbidity and Mortality among Patients with Human Immunodeficiency Virus InfectionClinical Infectious Diseases, 2001
- Increasing Mortality Due to End-Stage Liver Disease in Patients with Human Immunodeficiency Virus InfectionClinical Infectious Diseases, 2001
- Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1998
- Mortality from liver cancer and liver disease in haemophilic men and boys in UK given blood products contaminated with hepatitis CThe Lancet, 1997
- The Risk of Transfusion-Transmitted Viral InfectionsNew England Journal of Medicine, 1996
- Obstetrical Factors and the Transmission of Human Immunodeficiency Virus Type 1 from Mother to ChildNew England Journal of Medicine, 1996
- Mother-to-infant transmission of hepatitis C virusThe Lancet, 1995
- Transfusion-Associated Hepatitis and AIDSNew England Journal of Medicine, 1987
- RISK FACTORS FOR SEROCONVERSION TO HUMAN IMMUNODEFICIENCY VIRUS AMONG MALE HOMOSEXUALSThe Lancet, 1987